Use of quetiapine in bipolar disorder: A case series with prospective evaluation

T. Suppes, S. L. McElroy, P. E. Keck, L. Altshuler, M. A. Frye, H. Grunze, G. S. Leverich, W. A. Nolen, K. Chisholm, E. B. Dennehy, R. M. Post

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


Quetiapine, a new atypical antipsychotic, was added to ongoing treatment of bipolar I outpatients (n=15) for symptoms of illness (mood lability, irritability, psychosis and/ or difficulty sleeping). All evaluations were prospectively obtained, with the majority of patients (n=9) showing much or very much improvement on the Clinical Global Impression for Bipolar Disorder (CGI-BP). Somatic complaints were limited. Mean (SD) duration before changes in medication regimens was 134 (100) days. Studies of the use of quetiapine in maintenance treatment of bipolar disorder are warranted.

Original languageEnglish (US)
Pages (from-to)173-174
Number of pages2
JournalInternational Clinical Psychopharmacology
Issue number3
StatePublished - May 2004


  • Bipolar disorder
  • Maintenance
  • Outpatient
  • Polypharmacy
  • Quetiapine
  • Treatment

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)


Dive into the research topics of 'Use of quetiapine in bipolar disorder: A case series with prospective evaluation'. Together they form a unique fingerprint.

Cite this